MedTrace Logo

Assessment of Implant Fixation and SF-36 for Short Hip-Stems - A Prospective Clinical Study

NCT04172129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-11-27

No results posted yet for this study

Summary

The primary purpose of this study was to evaluate the implant fixation of the NANOS™ Neck Preserving Hip Stem (OHST Medizintechnik AG, distributed by Smith \& Nephew GmbH, Marl, Germany) by measuring the migration of the implant using the model-based roentgen stereophotogrammetric analysis (MBRSA).

Conditions

  • Primary and Secondary Coxarthrosis
  • Dysplasia Coxarthrosis
  • Post-traumatic Necrosis of the Femoral Head

Interventions

DEVICE

Total Hip Arthroplasty

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    lead INDUSTRY

Principal Investigators

  • Henning Windhagen, Prof. Dr. med. · Orthopädische Klinik der Medizinischen Hochschule Hannover

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-26
Primary Completion
2017-01-04
Completion
2017-02-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04172129 on ClinicalTrials.gov